Bacterial joint infections are a devastating complication, causing pain, death, and costly treatments. While current diagnostics are either slow and unreliable or expensive and complex, acib’s Point-of-Care (POC) test provides fast, accurate results at low cost.
Tired of slow and inaccurate aspergillosis diagnostics? acib’s innovative DNA aptamer technology revolutionizes diagnostics with precision and speed.
Did you know that HMOs are not only important for healthy infant development, but can also serve as a prebiotic for adults, contribute to combating allergies and diabetes and enhance the effectiveness of vaccines and antibiotics? And did you know
Ene-reductases are the gold standard for alkene reduction in biocatalysis. However, their industrial implementation is hampered by their requirement for costly nicotinamide coenzymes. We aim to reduce these costs by smart enzyme engineering.
Helicobacter pylori and Campylobacter spp. are leading causes of gastrointestinal illness worldwide. Existing solutions are limited, and there’s a need for broad-spectrum protection. acib offers a dual-protection vaccine platform using H. pylori to deliver Campylobacter antigens, potentially reducing development time
Are you grappling with challenges related to protein stability, activity, expression, or purification? Look no further – the Austrian Centre of Industrial Biotechnology (acib) offers new machine learning and neural network tools to predict better protein variants with unprecedented accuracy.
Uncertain about a (bio)plastic’s true sustainability? acib’s enzymatic degradation studies provide the answer you need. Let acib help you unveiling the fate of your (bio)polymer in various environments.
The global digestive health market is projected to reach EUR 90 billion by 2023. Existing treatments often have limitations. Milk extracellular vesicles (mEVs) offer a natural solution to promote gut health, strengthen protective barriers and reduce inflammation. acib can help
The demand for sustainable and economically viable sources of pharmaceutical compounds is on the rise. Traditional methods rely heavily on petrochemicals, leading to environmental pollution and resource depletion. By utilizing lignin, a major component of biomass, as a starting material
Understanding molecular details of proteins is critical for sucessful drug discovery, protein engineering or formulation development. However, traditional techniques often struggle to capture the dynamic nature of proteins in solution. Let us help you overcome this challenge using HDX-MS!
